We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
MESALAZINE SUN/ MESALZ (Sun Pharma ANZ Pty Ltd)
Product name
MESALAZINE SUN/ MESALZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
129 (255 working days)
Active ingredients
Mesalazine
Registration type
New generic medicine
Indication
For the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.